PTC Therapeutics | PTCT - 流动资产

股票价格
68.23
每天变化
-0.36 -0.52%
每月一次
2.22%
每年
37.75%
Q2 预测
66.77


金融业
股票价格
USD
资产
USD 2.9B
现金及等价物
USD 984.65M
销售成本
USD 16.3M
流动资产
USD 2.27B
流动负债
USD 968.43M
债务
USD 2.71B
EBIT
USD -81.62M
EBITDA
USD -70.99M
员工
939
EPS每股收益
USD -1.67
股本和储备
USD -205.31M
销售毛利
USD 148.38M
债务利息支出
USD 50.58M
贷款资金
USD 2.03B
市值
USD 5.25B
净收入
USD -134.97M
营业费用
USD 246.3M
营业利润
USD -81.62M
普通股股本
USD 81.47M
PE价格收益
9.98
税前利润
USD -139.08M
销售收入
USD 164.7M
销售和管理费用
USD 87.2M
股票
USD 79.65M
贸易债权人
USD 45.49M
应收帐款人
USD 181.62M


流动资产 更改 日
Acadia Pharmaceuticals USD 1.06B 14.31M 2025-12
Alnylam Pharmaceuticals USD 4.05B 97.85M 2025-12
Amgen USD 29.06B 1.17B 2025-12
BioCryst Pharmaceuticals USD 404.35M 48.66M 2025-12
Biogen USD 8.97B 37.5M 2025-12
BioMarin Pharmaceutical USD 3.95B 98.95M 2025-12
Cytokinetics USD 916.97M 60.37M 2025-12
Daiichi Sankyo JPY 2.1T 218.5B 2025-12
Enanta Pharmaceuticals USD 198.68M 5.65M 2025-12
Esperion Therapeutics USD 462.57M 102.11M 2025-12
Gilead Sciences USD 19.89B 1.05B 2025-12
Incyte USD 5.02B 746.01M 2025-12
Ionis Pharmaceuticals USD 2.99B 471.01M 2025-12
Ironwood Pharmaceuticals USD 273.84M 82.09M 2025-09
Karyopharm Therapeutics USD 103.15M 13.4M 2025-12
Novartis USD 30.46B 2.26B 2025-12
Pfizer USD 46.92B 3.22B 2025-09
PTC Therapeutics USD 2.27B 266.14M 2025-12
Puma Biotechnology USD 143.58M 7M 2025-09
Roche Holding CHF 38.73B 3.03B 2025-12
Sangamo BioSciences USD 49.89M 12.3M 2025-06
Sarepta Therapeutics USD 2.54B 184.37M 2025-12
TG Therapeutics USD 630.76M 31M 2025-12
Ultragenyx Pharmaceutical USD 643.21M 76.58M 2025-09
Vertex Pharmaceuticals USD 11.2B 631.4M 2025-12
Xencor USD 599.82M 81.38M 2025-12